The Company announced today its first significant achievement towards that vision with the nationwide launch of its direct-to-cultivator sales network and automated replenishment services beginning in 17 states.
Recognized leader in the specialty hydroponics industry restates non-cash losses for first quarter 2014, and adheres to stronger financial controls
Mark E. Scott, a highly qualified financial executive brings three decades of experience to advise the Company on growth investments and fiscal responsibility efforts
GrowLife announced the decision made by Sterling Scott to depart as CEO and Director and Chairman of the Board for personal reasons. Marco Hegyi, Company President, will assume Mr. Scott's CEO duties and responsibilities, and continue to drive development and expansion strategies.
A new compensation plan for independent Directors on GrowLife's Board has been proposed to replace the stock award plan originally established in August 2012.
GrowLife understands that trading in GrowLife securities will resume during market hours on Friday, April 25, 2014.
GrowLife, Inc. (PHOT) has introduced a new shareholder hotline and email communication system to address anticipated increases in shareholder questions over the next several days.
This communication is to inform shareholders of the information available to the Company and to directly address, to the extent possible, several of the many questions that we have heard from shareholders and investors.
GrowLife continues business as usual while reaching-out to the SEC to determine the basis of its inquiry...
Nutrients and supplements for growing legal cannabis are a major part of GrowLife's business in its retail and online sales channels.
In its annual report, GrowLife posts a 235% gain in year-over-year sales revenue for 2013.
Two industry leaders have signed a letter of intent to create patentable technology for developing pharmaceutical grade processes for cannabis extractions.
GrowLife's Infrastructure Funding and Technology program (GIFT) allows fully-licensed and compliant growers and dispensaries in well-regulated cannabis markets to spread the cost of infrastructure builds over time...
In 2013, GrowLife engaged Medicus Research, LLC to provide a comprehensive review of worldwide scientific literature on the therapeutic benefits of medical marijuana. Medicus Research is a premier organization engaged in clinical ...
"GrowLife's engagement and role within the quickly evolving cannabis industry has expanded recently," stated GrowLife, Inc. CEO Sterling Scott, "And we are responding to events through targeted offerings of an infrastructure ...
The new line of professional components will be co-branded under FusionPharm's PharmPod™ brand name and GrowLife's Stealth Grow™ line of equipment. This co-branded component line will initially include a line of professional...
CEN Biotech, working under the inspection and authority of Health Canada, has completed the extraordinary governmental processes in Canada to receive approval to begin constructing their state of the art medical marijuana facility in...
RXNB is an investment company with holdings in drug formulation, manufacturing, and distribution. The company represents a recent roll-up of several independent companies in the pharmaceutical and nutraceutical market...